TapImmune Inc (OTCQB:TPIV)

Data as of Apr 17
 -0.25 / -8.47%
Today’s Change
Today|||52-Week Range
Consumer Services
Other Consumer Services

Company Description

TapImmune, Inc. is biotechnology company that specializing in the development of innovative therapeutics and vaccines in the areas of oncology and infectious disease. The company's product, the TAP vaccine performs a key step in moving characteristic markers called antigens to the surfaces of cells. It was founded in 1991 and is headquartered in Seattle, WA.

Contact Information

TapImmune, Inc.
1551 Eastlake Avenue East
Seattle Washington 98102
P:(206) 504-7279
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Glynn WilsonChairman, Chief Executive Officer, CFO & Secretary
Mark ReddishDirector & Vice President-Product Development
Robert Z. FlorkiewiczSenior Director-Molecular Biology & Virology
Venissa IzaguirreProject Manager
Thad MorrisHead-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.